These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 17984229

  • 1. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
    [Abstract] [Full Text] [Related]

  • 2. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
    Wong D, Wong T, Romney M, Leung V.
    BMC Infect Dis; 2016 May 23; 16():224. PubMed ID: 27215201
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
    Wong D, Wong T, Romney M, Leung V.
    Ann Clin Microbiol Antimicrob; 2016 Apr 26; 15():27. PubMed ID: 27112143
    [Abstract] [Full Text] [Related]

  • 4. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.
    Aguado JM, San-Juan R, Lalueza A, Sanz F, Rodríguez-Otero J, Gómez-Gonzalez C, Chaves F.
    Emerg Infect Dis; 2011 Jun 26; 17(6):1099-102. PubMed ID: 21749780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Truong J, Veillette JJ, Forland SC.
    Antimicrob Agents Chemother; 2018 Feb 26; 62(2):. PubMed ID: 29133561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
    Falcón R, Mateo E, Oltra R, Giménez E, Albert E, Torres I, Navarro D.
    Eur J Clin Microbiol Infect Dis; 2019 May 26; 38(5):903-912. PubMed ID: 30729396
    [Abstract] [Full Text] [Related]

  • 11. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E, Chambers HF, Doernberg S.
    Antimicrob Agents Chemother; 2016 Sep 26; 60(9):5276-84. PubMed ID: 27324762
    [Abstract] [Full Text] [Related]

  • 12. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores.
    Kim SH, Park WB, Lee CS, Kang CI, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.
    Clin Microbiol Infect; 2006 Jan 26; 12(1):13-21. PubMed ID: 16460541
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
    Panesso D, Planet PJ, Diaz L, Hugonnet JE, Tran TT, Narechania A, Munita JM, Rincon S, Carvajal LP, Reyes J, Londoño A, Smith H, Sebra R, Deikus G, Weinstock GM, Murray BE, Rossi F, Arthur M, Arias CA.
    Emerg Infect Dis; 2015 Oct 26; 21(10):1844-8. PubMed ID: 26402569
    [Abstract] [Full Text] [Related]

  • 15. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
    McConeghy KW, Bleasdale SC, Rodvold KA.
    Clin Infect Dis; 2013 Dec 26; 57(12):1760-5. PubMed ID: 23985343
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy.
    Park GE, Ko JH, Cho SY, Ha YE, Lee NY, Kang CI, Chung DR, Song JH, Peck KR.
    Eur J Clin Microbiol Infect Dis; 2017 Jul 26; 36(7):1091-1096. PubMed ID: 28078559
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.